Inhibitors of HBV replication of formula (I) including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R1-R5, B and Z have the meaning as defined herein. The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use, alone or in combination with other HBV inhibitors, in HBV therapy.
公式(I)的HBV复制
抑制剂包括立体
化学同分异构体形式,以及其盐、
水合物和溶剂合物,其中R1-R5、B和Z的含义如本文所定义。本发明还涉及制备所述化合物的方法、含有它们的药物组合物以及它们在HBV治疗中的使用,单独或与其他HBV
抑制剂结合使用。